Konstantin Matentzoglu
Directeur/Membre du Conseil chez Polpharma Biologics Group BV
Profil
Konstantin Matentzoglu is a Member-Supervisory Board at Polpharma Biologics Group BV.
He previously worked as the Chief Executive Officer at Celonic AG and as the SEVP-Business Development & Operations at AYOXXA Biosystems GmbH.
He holds a doctorate degree from Universität Konstanz.
Postes actifs de Konstantin Matentzoglu
Sociétés | Poste | Début |
---|---|---|
Polpharma Biologics Group BV | Directeur/Membre du Conseil | - |
Anciens postes connus de Konstantin Matentzoglu
Sociétés | Poste | Fin |
---|---|---|
Celonic AG
Celonic AG BiotechnologyHealth Technology Celonic AG engages in the development and contract manufacturing of biologics. It offers services such as cell line development, upstream and downstream processing development, good manufacturing process manufacturing, and fill and finish services for liquid formulated drug products. The company is headquartered in Basel, Switzerland. | Directeur Général | - |
AYOXXA Biosystems GmbH
AYOXXA Biosystems GmbH BiotechnologyHealth Technology AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany. | Directeur des opérations | - |
Formation de Konstantin Matentzoglu
Universität Konstanz | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 3 |
---|---|
Celonic AG
Celonic AG BiotechnologyHealth Technology Celonic AG engages in the development and contract manufacturing of biologics. It offers services such as cell line development, upstream and downstream processing development, good manufacturing process manufacturing, and fill and finish services for liquid formulated drug products. The company is headquartered in Basel, Switzerland. | Health Technology |
AYOXXA Biosystems GmbH
AYOXXA Biosystems GmbH BiotechnologyHealth Technology AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany. | Health Technology |
Polpharma Biologics Group BV |